Grant: Engage Grants Program
Simon Fraser University
$23,660.00
Optical probe development for dual-function imaging agents
FY 2009-10
Summary
This short-term research proposal aims to develop and test the optical imaging properties of a series of
compounds that are currently under development as radiopharmaceutical agents. Radiopharmaceuticals allow
for the noninvasive detection of biological processes within the body.
In collaboration with MDS Nordion (a Canadian company), we aim to expand the versatility of a series of
macrocyclic chelates towards their use as optical probes. Visualization of optical probes via fluorescence
microscopy allows for the study of uptake and localization at the cellular and subcellular level, thereby
affording information on the mechanisms responsible for localization in certain tissues such as tumours. This
data can then be correlated with in vivo radioimaging studies using gamma-emitting pharmaceuticals.
Demonstrating the optical imaging capacity of the probes under development as radiopharmaceutical agents at
MDS Nordion will greatly increase the appeal of these compounds. Researchers exploring optical probes do
not need to conduct research in close proximity to radiochemistry facilities, and are not bound by the timeline
imposed by radionuclide decay. The additional imaging modality allows for the efficient screening of new
agents via optical imaging at the cellular level, and in combination with in vivo radioimaging studies, provides
complementary information on biological processes under study.
Program
Engage Grants Program
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
395890-2009
Name nom
Storr, Timothy
Department département
Chemistry
Organization id
5
Institution établissement
Simon Fraser University
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2009
Award amount
23660
Program id
EGP
Program nane en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3603
Research subject group en
Inorganic chemistry
Research subject group fr
Chimie inorganique
Research subject en
Bio-inorganic chemistry
Research subject fr
Chimie bio-inorganique
Partie
1
Nb partie
1
Application title
Optical probe development for dual-function imaging agents
Keyword
NA
Application summary
This short-term research proposal aims to develop and test the optical imaging properties of a series of
compounds that are currently under development as radiopharmaceutical agents. Radiopharmaceuticals allow
for the noninvasive detection of biological processes within the body.
In collaboration with MDS Nordion (a Canadian company), we aim to expand the versatility of a series of
macrocyclic chelates towards their use as optical probes. Visualization of optical probes via fluorescence
microscopy allows for the study of uptake and localization at the cellular and subcellular level, thereby
affording information on the mechanisms responsible for localization in certain tissues such as tumours. This
data can then be correlated with in vivo radioimaging studies using gamma-emitting pharmaceuticals.
Demonstrating the optical imaging capacity of the probes under development as radiopharmaceutical agents at
MDS Nordion will greatly increase the appeal of these compounds. Researchers exploring optical probes do
not need to conduct research in close proximity to radiochemistry facilities, and are not bound by the timeline
imposed by radionuclide decay. The additional imaging modality allows for the efficient screening of new
agents via optical imaging at the cellular level, and in combination with in vivo radioimaging studies, provides
complementary information on biological processes under study.